Mahamaya Lifesciences SME IPO Subscription Status
Mahamaya Lifesciences SME IPO closed on 13 November 2025 with an overall subscription of 1.63x based on shares applied. QIB demand came in at 1.19x, NII at 3.99x, and retail at 1.02x.
Allotment will be finalised on 14 November 2025. The stock is scheduled to list on NSE and BSE on 18 November 2025.
Issue Price
Rs 114.00
GMP Today
-
Overall Subscription
1.63x
Issue Size
₹66.91 Cr
Allotment Date
14 Nov 2025
Listing Date
18 Nov 2025
Mahamaya Lifesciences SME IPO Subscription by Amount
Category-wise subscription based on amount applied at issue price Rs 114.00
| Category | Amount Offered | Amount Applied | Subscription |
|---|---|---|---|
| QIB | Rs 13.41 Cr | Rs 15.98 Cr | 1.19x |
| FII | - | Rs 6.66 Cr | - |
| DFI | - | - | - |
| Mutual Funds | - | - | - |
| Other | - | Rs 9.32 Cr | - |
| NII | Rs 10.05 Cr | Rs 40.07 Cr | 3.99x |
| bNII (above Rs 10L) | Rs 6.70 Cr | Rs 37.06 Cr | 5.53x |
| Corporate | - | Rs 8.56 Cr | - |
| Individual | - | Rs 25.54 Cr | - |
| Other | - | Rs 2.95 Cr | - |
| sNII (Rs 2L to Rs 10L) | Rs 3.35 Cr | Rs 3.01 Cr | 0.90x |
| Corporate | - | Rs 8.21 L | - |
| Individual | - | Rs 2.93 Cr | - |
| Other | - | - | - |
| IND | Rs 23.47 Cr | Rs 24.02 Cr | 1.02x |
| Fixed price | - | Rs 24.02 Cr | - |
| Total | Rs 46.94 Cr | Rs 80.07 Cr | 1.71x |
Mahamaya Lifesciences SME IPO Subscription by Applications
Category-wise subscription based on applications received
| Category | Applications Offered | Applications Received | Subscription |
|---|---|---|---|
| QIB | 980 | 9 | 0.01x |
| FII | - | 2 | - |
| DFI | - | - | - |
| Mutual Funds | - | - | - |
| Other | - | 7 | - |
| NII | 245 | 146 | 0.60x |
| bNII (above Rs 10L) | 163 | 83 | 0.51x |
| Corporate | - | 17 | - |
| Individual | - | 39 | - |
| Other | - | 27 | - |
| sNII (Rs 2L to Rs 10L) | 82 | 63 | 0.77x |
| Corporate | - | 2 | - |
| Individual | - | 61 | - |
| Other | - | - | - |
| IND | 858 | 878 | 1.02x |
| Fixed price | - | 878 | - |
| Total | 2,083 | 1,033 | 0.50x |
What Do These Subscription Numbers Mean?
A subscription of 1.63x by shares means the IPO received bids for 2 times the shares reserved. Allotment odds depend on application count in each category, not share volume.
Here is what each category number tells you:
QIB at 1.19x by shares: This is the strongest signal on the page. QIBs are institutional investors, mutual funds, foreign institutions, and banks. When they subscribe at 1.19x, it reflects serious institutional conviction.
NII at 0.60x by applications: NII includes high net worth individuals applying above Rs 2 lakh. Proportional allotment uses application subscription. bNII came in at 0.51x and sNII at 0.77x by applications. Share subscription was 3.99x. Allotment uses application count, not share volume.
At 1.02x subscription by applications, approximately 1 in 1 retail applicants can expect an allotment (~98% per application). Retail allotment is done by lottery when oversubscribed.
Mahamaya Lifesciences SME IPO Allotment Chances
Allotment odds below use application subscription (number of bids received), not share or amount subscribed.
Retail (IND)
- •Application subscription: 1.02x.
- •Allotment odds: about 1 in 1 (~98% chance per application).
- •Method: Lottery. If allotted, you receive at least one lot.
- •One application per PAN. Multiple eligible accounts in a household can improve overall family odds, not individual odds.
SHNI (Rs 2 lakh to Rs 10 lakh)
- •Application subscription: 0.77x.
BHNI (above Rs 10 lakh)
- •Application subscription: 0.51x.
- •Share subscription was 5.53x. Allotment uses application count, not share volume.
Check the Mahamaya Lifesciences SME IPO Allotment Status page from 14 November 2025 for your allotment result.
Mahamaya Lifesciences SME IPO Day-wise Subscription
| Day | QIB | NII | Retail | Overall |
|---|---|---|---|---|
| Day 1 - 11 Nov 2025 | 0.00x | 0.35x | 0.07x | 0.11x |
| Day 2 - 12 Nov 2025 | 0.65x | 0.27x | 0.20x | 0.34x |
| Day 3 - 13 Nov 2025 | 1.19x | 3.63x | 1.02x | 1.63x |
Mahamaya Lifesciences SME IPO Key Dates
| Event | Date |
|---|---|
| IPO Open Date | 11 November 2025 |
| IPO Close Date | 13 November 2025 |
| Allotment Date | 14 November 2025 |
| Refund Initiation | 15 November 2025 |
| Share Credit to Demat | 15 November 2025 |
| Listing Date | 18 November 2025 |
| Minimum Investment | Rs 2,73,600.00 |
| Lot Size | 1200 shares |
About Mahamaya Lifesciences SME
No company information available
Understanding Subscription Categories
QIB - Qualified Institutional Buyers
Includes foreign institutional investors, domestic financial institutions, mutual funds, and other qualified institutions. QIB demand is considered the most reliable indicator of institutional confidence in an IPO.
NII - Non-Institutional Investors
High net worth individuals applying above Rs 2 lakh. Divided into bNII (above Rs 10 lakh) and sNII (Rs 2 lakh to Rs 10 lakh). NII allotment is proportional.
IND - Individual Investors
Investors applying up to Rs 2 lakh per PAN. Allotment is by lottery when oversubscribed. Minimum one lot per successful applicant.
Mahamaya Lifesciences SME IPO GMP Today
Live GMP, listing price estimate, and listing gain
Mahamaya Lifesciences SME IPO Allotment Status
Check allotment result on allotment date
Mahamaya Lifesciences SME IPO Details
Financials, peers, strengths, and review
All IPO Subscription Status
Subscription for all active IPOs
Mahamaya Lifesciences SME IPO Subscription FAQs
What is Mahamaya Lifesciences SME IPO subscription status today?
Mahamaya Lifesciences SME IPO subscription closed on 13 November 2025 with overall subscription of 1.63x (by shares) as of 27 June 2026, 3:17 AM IST. QIB 1.19x, NII 0.60x, IND 1.02x.
What is the overall subscription of Mahamaya Lifesciences SME IPO?
Mahamaya Lifesciences SME IPO is subscribed 1.63x overall by shares at close on 13 November 2025. QIB 1.19x, NII 0.60x, and IND 1.02x.
What is Mahamaya Lifesciences SME IPO QIB subscription?
Mahamaya Lifesciences SME IPO QIB (Qualified Institutional Buyers) subscription is 1.19x by shares. QIB includes mutual funds, FIIs, banks, and other institutions.
What is Mahamaya Lifesciences SME IPO IND subscription?
Mahamaya Lifesciences SME IPO IND subscription is 1.02x by applications. Minimum retail bid is up to Rs 2 lakh per PAN.
What is Mahamaya Lifesciences SME IPO NII subscription?
Mahamaya Lifesciences SME IPO NII (Non-Institutional Investors) subscription is 0.60x by applications. NII covers bids above Rs 2 lakh.
What are allotment chances in Mahamaya Lifesciences SME IPO for retail?
At 1.02x subscription by applications, approximately 1 in 1 retail applicants can expect an allotment (~98% per application). Allotment is done by lottery.
When is Mahamaya Lifesciences SME IPO allotment date?
Mahamaya Lifesciences SME IPO allotment date is 14 November 2025. Check Mahamaya Lifesciences SME IPO Allotment Status on IPOwiz from that day using your PAN.
When does Mahamaya Lifesciences SME IPO subscription close?
Mahamaya Lifesciences SME IPO subscription closed on 13 November 2025. No new applications are accepted after the close.
What is Mahamaya Lifesciences SME IPO GMP today?
GMP for Mahamaya Lifesciences SME IPO is not available yet. Track Mahamaya Lifesciences SME IPO GMP Today on IPOwiz once grey market activity starts.
What is Mahamaya Lifesciences SME IPO issue price and lot size?
Mahamaya Lifesciences SME IPO issue price is ₹114 per share. Lot size is 1200 shares. Minimum investment is ₹2,73,600 per lot (minimum 2 lots for SME). Issue size: ₹66.91 Cr.
When is Mahamaya Lifesciences SME IPO listing date?
Mahamaya Lifesciences SME IPO listing date is 18 November 2025 on NSE and BSE. Allotment is on 14 November 2025.
How does subscription affect Mahamaya Lifesciences SME IPO allotment?
Allotment odds in Mahamaya Lifesciences SME IPO depend on application subscription in each category, not share volume. Retail uses lottery when oversubscribed. NII uses proportional allotment by applications. At 1.63x overall, competition is moderate.
For allotment results from 14 November 2025, visit the Mahamaya Lifesciences SME IPO Allotment Status page. For listing day updates on 18 November 2025, download the IPOwiz App.
Reviewed by Dinesh Agrawal
15+ years in Indian capital markets and IPO research. Subscription data verified before publish.